Drug news
Ellipse Cardioverter Defibrillator ( St Jude) receives CE Mark
CE Mark approval has been granted for the Ellipse implantable cardioverter defibrillator (ICD)from st Jude Medical. Designed with feedback from more than 200 physicians from around the world, the Ellipse ICD provides the benefits of advanced features and power in the industry's smallest high-energy Implantable Cardioverter Defribillator.Designed with feedback from more than 200 physicians from around the world, the Ellipse ICD provides the benefits of advanced features and power in the industry's smallest high-energy Implantable Cardioverter Defribillator.The updated programming in ShockGuard technology provides more accurate sensing and is able to better discriminate between rhythms that require defibrillation and those that do not.The Ellipse ICD's unique shape was conceptualized by physicians during focus groups in which they crafted in clay their vision for the ideal device design. The physician-inspired shape is unlike any currently available, with each of the enhancements designed to increase patient comfort or make the device easier to implant.